Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

PHASE2CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

February 27, 2020

Study Completion Date

October 5, 2021

Conditions
Adverse Reaction to Cholera VaccineCholera Vaccination Reaction
Interventions
BIOLOGICAL

killed whole cell oral cholera vaccine

two week interval

Trial Locations (1)

Unknown

M.A. Sante, Douala

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Meilleur Accès aux Soins de Santé (M.A. Santé)

UNKNOWN

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03719066 - Extended Dose Intervals With Oral Cholera Vaccine in Cameroon | Biotech Hunter | Biotech Hunter